Int J Angiol 2016; 25(03): 165-167
DOI: 10.1055/s-0036-1572524
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Safety and Effectiveness of Closure Devices Applied to a Stented Common Femoral Artery: A Retrospective Analysis

Nicolas W. Shammas
1   Midwest Cardiovascular Research Foundation, Davenport, Iowa
,
Gail A. Shammas
1   Midwest Cardiovascular Research Foundation, Davenport, Iowa
,
Thomas Harris
1   Midwest Cardiovascular Research Foundation, Davenport, Iowa
,
Cara M. Voelliger
1   Midwest Cardiovascular Research Foundation, Davenport, Iowa
,
Andrew N. Shammas
1   Midwest Cardiovascular Research Foundation, Davenport, Iowa
,
Michael Jerin
1   Midwest Cardiovascular Research Foundation, Davenport, Iowa
› Author Affiliations
Further Information

Publication History

Publication Date:
18 February 2016 (online)

Abstract

Bailout stenting of the common femoral artery (CFA) may become necessary with failed balloon angioplasty or atherectomy or in case of bleeding requiring a covered stent over the arteriotomy site. Reaccessing the CFA through a previously placed stent may occur during angiography. The safety and effectiveness of applying a closure device, or manual compression to achieve hemostasis through an accessed stented CFA are unknown. All patients in our practice that underwent CFA stenting were identified using billing records for 3 years (January 1, 2010–February 28, 2013). Patients were included if there has been documentation of access through the stented CFA segment on angiography. In-hospital and up to 2 weeks postdischarge major adverse events were recorded from medical records. A total of 48 patients were included in the study. The mean age was 65.9 ± 10.9 years, males 60.4%. Perclose (Abbott Vascular, Santa Clara, CA) was used in 85.7%, AngioSeal (St. Jude Medical, St. Paul, MN) in 8.3%, Mynx (Access Closure, Santa Clara, CA) in 2%, and manual compression in 4% of the patients. Major adverse events consisted of in-hospital mortality in two patients: one probably related to index access-site thrombosis complicated by subsequent acute renal failure following reintervention; the other mortality was related to major bleeding possibly related to the index access site. The remaining patients had no adverse events and there were no reported problems at 2 weeks follow-up. Accessing and applying closure device in stented CFA can be accomplished successfully in approximately 96% of the patients with low major adverse events.

 
  • References

  • 1 Schulz-Schüpke S, Helde S, Gewalt S , et al; Instrumental Sealing of Arterial Puncture Site—CLOSURE Device vs Manual Compression (ISAR-CLOSURE) Trial Investigators. Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial. JAMA 2014; 312 (19) 1981-1987
  • 2 Kara K, Kahlert P, Mahabadi AA , et al. Comparison of collagen-based vascular closure devices in patients with vs. without severe peripheral artery disease. J Endovasc Ther 2014; 21 (1) 79-84